Literature DB >> 18033242

Fabry disease: an underrecognized cause of proteinuria.

F C Fervenza1, R Torra, D J Lager.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18033242     DOI： 10.1038/sj.ki.5002677

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  10 in total

Review 1.  Fabry's disease: an example of cardiorenal syndrome type 5.

Authors:  Aashish Sharma; Marco Sartori; Jose J Zaragoza; Gianluca Villa; Renhua Lu; Elena Faggiana; Alessandra Brocca; Luca Di Lullo; Sandro Feriozzi; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

Review 2.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

3.  Isolated microalbuminuria as the first clinical presentation of Fabry disease in an adult heterozygous female.

Authors:  Renzo Mignani; Paola Preda; Antonio Granata; Laura Maldini; Paola De Giovanni; Marcello Montevecchi; Angelo Rigotti; Leonardo Cagnoli
Journal:  NDT Plus       Date:  2009-08-11

4.  Renal involvement in Neimann-Pick Disease.

Authors:  Carrie A Grafft; Fernando C Fervenza; Merfake H Semret; Sheldon Orloff; Sanjeev Sethi
Journal:  NDT Plus       Date:  2009-08-10

5.  Fabry disease: the many faces of a single disorder.

Authors:  Roser Torra; Alberto Ortíz
Journal:  Clin Kidney J       Date:  2012-10

6.  Retinal hyperreflective foci in Fabry disease.

Authors:  Yevgeniya Atiskova; Rahman Rassuli; Anja Friederike Koehn; Amir Golsari; Lars Wagenfeld; Marcel du Moulin; Nicole Muschol; Simon Dulz
Journal:  Orphanet J Rare Dis       Date:  2019-12-26       Impact factor: 4.123

7.  Human kidney organoids reveal the role of glutathione in Fabry disease.

Authors:  Jin Won Kim; Hyung Wook Kim; Sun Ah Nam; Jong Young Lee; Hae Jin Cho; Tae-Min Kim; Yong Kyun Kim
Journal:  Exp Mol Med       Date:  2021-10-15       Impact factor: 8.718

8.  Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease.

Authors:  Fernando C Fervenza; Roser Torra; David G Warnock
Journal:  Biologics       Date:  2008-12

9.  Cardiomyopathy and response to enzyme replacement therapy in a male mouse model for Fabry disease.

Authors:  Aurelie Nguyen Dinh Cat; Brigitte Escoubet; Vincent Agrapart; Violaine Griol-Charhbili; Trenton Schoeb; Wenguang Feng; Edgar Jaimes; David G Warnock; Frederic Jaisser
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

Review 10.  Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?

Authors:  Stephen Waldek; Sandro Feriozzi
Journal:  BMC Nephrol       Date:  2014-05-06       Impact factor: 2.388
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.